148 related articles for article (PubMed ID: 29954817)
21. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
22. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.
Kobayashi K; Hirata K; Yamaguchi S; Manabe O; Terasaka S; Kobayashi H; Shiga T; Hattori N; Tanaka S; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1071-80. PubMed ID: 25852010
[TBL] [Abstract][Full Text] [Related]
24. 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.
Singhal T; Narayanan TK; Jacobs MP; Bal C; Mantil JC
J Nucl Med; 2012 Nov; 53(11):1709-15. PubMed ID: 23055534
[TBL] [Abstract][Full Text] [Related]
25. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
[TBL] [Abstract][Full Text] [Related]
26. Association Between Pretreatment
Kaneko K; Koriyama S; Tsuzuki S; Masui K; Kanasaki R; Yamamoto A; Nagao M; Muragaki Y; Kawamata T; Sakai S
World Neurosurg; 2024 Jun; 186():e495-e505. PubMed ID: 38583563
[TBL] [Abstract][Full Text] [Related]
27. Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.
Zaragori T; Castello A; Guedj E; Girard A; Galldiks N; Albert NL; Lopci E; Verger A
Clin Nucl Med; 2021 Jan; 46(1):e36-e37. PubMed ID: 32804767
[TBL] [Abstract][Full Text] [Related]
28. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329
[TBL] [Abstract][Full Text] [Related]
29. Comparison of diffusion tensor imaging and
Kinoshita M; Arita H; Okita Y; Kagawa N; Kishima H; Hashimoto N; Tanaka H; Watanabe Y; Shimosegawa E; Hatazawa J; Fujimoto Y; Yoshimine T
J Neurosurg; 2016 Nov; 125(5):1136-1142. PubMed ID: 26918477
[TBL] [Abstract][Full Text] [Related]
30. Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.
Jansen NL; Suchorska B; Wenter V; Eigenbrod S; Schmid-Tannwald C; Zwergal A; Niyazi M; Drexler M; Bartenstein P; Schnell O; Tonn JC; Thon N; Kreth FW; la Fougère C
J Nucl Med; 2014 Feb; 55(2):198-203. PubMed ID: 24379223
[TBL] [Abstract][Full Text] [Related]
31. Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas.
Pyka T; Gempt J; Hiob D; Ringel F; Schlegel J; Bette S; Wester HJ; Meyer B; Förster S
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):133-141. PubMed ID: 26219871
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography with injection of methionine as a prognostic factor in glioma.
De Witte O; Goldberg I; Wikler D; Rorive S; Damhaut P; Monclus M; Salmon I; Brotchi J; Goldman S
J Neurosurg; 2001 Nov; 95(5):746-50. PubMed ID: 11702862
[TBL] [Abstract][Full Text] [Related]
33. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic significance of regional blood flow, blood volume, oxygen extraction fraction, and metabolic rates of oxygen and glucose as measured by positron emission tomography in patients with gliomas].
Mineura K; Suda Y; Sasajima T; Yasuda T; Kowada M; Ogawa T; Shishido F; Uemura K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2556-62. PubMed ID: 2614191
[TBL] [Abstract][Full Text] [Related]
35. The roles of
Kim S; Kim D; Kim SH; Park MA; Chang JH; Yun M
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1012-1020. PubMed ID: 29511838
[TBL] [Abstract][Full Text] [Related]
36. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
[TBL] [Abstract][Full Text] [Related]
37. Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T
J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671
[TBL] [Abstract][Full Text] [Related]
38. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.
Takahashi Y; Imahori Y; Mineura K
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5888-95. PubMed ID: 14676111
[TBL] [Abstract][Full Text] [Related]
40. Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas.
Roelcke U; Wyss MT; Nowosielski M; Rudà R; Roth P; Hofer S; Galldiks N; Crippa F; Weller M; Soffietti R
Neuro Oncol; 2016 May; 18(5):744-51. PubMed ID: 26578622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
